Three plants are part of the company’s pharmaceutical division, while the fourth plant is part of the medical device division. Johnson & Johnson will invest up to $225 million to expand the facilities, which will make way for more than 300 new jobs.
More Articles on Orthopedic Devices:
Arthritis Foundation to Honor Dr. James Marvel
Zimmer Celebrates 15 Years of Trabecular Metal for Joint Replacements
FOI, Florida Hospital to Launch Clinical Study of Spinal Device
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
